Skip to content

Anxiety: all studies

Page 744 of 773: studies 7,431 to 7,440 of 7,721, newest first. Back to the anxiety overview

Research

Mindfulness meditation: creative musical performance through awareness

March 27, 2006 Sheri Oyan 10 citations

Musicians spend countless hours practicing their instruments over the course of a lifetime. These hours are primarily spent learning how to manipulate the instrument through scale studies, etudes, and repertoire. However, despite intense and diligent effort, many musicians find themselves unable to perform for an audience without some kind of interruption in creativity in the form of mental...

Behavioral effects of ketamine and toxic interactions with psychostimulants

BMC Neuroscience March 16, 2006 T. Hayase, Yoshiko Yamamoto, Keiichi Yamamoto

BackgroundThe anesthetic drug ketamine (KT) has been reported to be an abused drug and fatal cases have been observed in polydrug users. In the present study, considering the possibility of KT-enhanced toxic effects of other drugs, and KT-induced promotion of an overdose without making the subject aware of the danger due to the attenuation of several painful subjective symptoms, the...

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Psychopharmacology March 15, 2006 Michael H. Baumann, Xiaoying Wang, Richard B Rothman 269 citations

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) is a widely abused illicit drug. In animals, high-dose administration of MDMA produces deficits in serotonin (5-HT) neurons (e.g., depletion of forebrain 5-HT) that have been interpreted as neurotoxicity. Whether such 5-HT deficits reflect neuronal damage is a matter of ongoing debate. OBJECTIVE: The present paper reviews four specific issues...

Psychiatric disorders and their correlates among young adult MDMA users in Ohio.

Journal of Psychoactive Drugs March 2006 Rüssel S. Falck, Robert G Carlson, Jichuan Wang et al.

This study describes the lifetime prevalence, correlates, and age of onset of selected psychiatric disorders among a community sample of MDMA users (n = 402), aged 18 to 30, in Ohio. Participants responded to interviewer-administered questionnaires, including sections of the computerized Diagnostic Interview Schedule for DSM-IV. Fifty-five percent of the sample had at least one lifetime...

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.

Journal of Psychopharmacology March 2006 Eleanor J Bull, Veronica Porkess, Michael Rigby et al.

The current study examined the long-term effect of brief exposure to 3,4-methylenedioxymethamphetamine (MDMA) on local cerebral glucose utilization (LCGU) in specific brain regions immediately following administration of the 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Wistar rats (post-natal day (PND) 28, n = 24) were administered MDMA (5 mg/kg, i.p.) or...

Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls

Journal of Psychopharmacology March 1, 2006 C. T. J. Lamers, Antoine Bechara, Matthew Rizzo et al. 113 citations

Repeated ecstasy (MDMA) use is reported to impair cognition and cause increased feelings of depression and anxiety. Yet, many relevant studies have failed to control for use of drugs other than MDMA, especially marijuana (THC). To address these confounding effects we compared behavioural performance of 11 MDMA/THC users, 15 THC users and 15 non-drug users matched for age and intellect. We...

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

Journal of Psychopharmacology March 1, 2006 Rainer Thomasius, P. Zapletalova, Kay Uwe Petersen et al. 158 citations

Although 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a known serotonergic neurotoxin in different animal species, there is to date no conclusive evidence of its neurotoxicity in humans. MDMA use was associated with impairments of psychological well-being, verbal memory and altered serotonergic functioning in a number of crosssectional studies. Due to inherent methodological...

Cannabis-Induced Koro-Like Syndrome

Urologia Internationalis 2006 C.K. Kalaitzi, A. Kalantzis 17 citations

The genital-shrinking syndrome is a transient state of acute anxiety characterized by the triad of a deep-seated fear of penile shrinkage, its disappearance into the abdomen, and apprehension regarding inevitable impotence or even death. It is also known by the Malayo-Indonesian term 'koro'. In the West, koro syndrome has been reported only in relation with various somatic, psychiatric and...

Interpreting Numinous Experiences

Social Analysis 2006 Dan Merkur 6 citations

Drawing on phenomenology and his clinical practice, the author explores religious experience and the dynamics of the numinous. The article opens with the argument that psychoanalysts, like religious healers, should be able to work with religious phenomena as part of psychoanalytic therapy. The origin of the term 'numinous' is explained, and two types of human religious experience, mysterium...

First-Known Hypnopompic Hallucination Occurring In-Hospital: Case Report

2006 Pauline Do

Despite the high prevalence of hypnopompic hallucinations in the community, to our knowledge there are no reports that have been published in the English literature of these phenomenon observed by staff in the hospital setting. Psychiatric or neurological evaluation often ensues if a patient reports hallucinations in other circumstances, but when they are reported in connection with sleep,...